TY - JOUR T1 - Digoxin initiation is associated with lower risk of all-cause readmission after hospitalisation for heart failure JF - Evidence Based Medicine JO - Evid Based Med SP - 153 LP - 153 DO - 10.1136/eb-2014-101743 VL - 19 IS - 4 AU - Adrian F Hernandez AU - Adam D DeVore Y1 - 2014/08/01 UR - http://ebm.bmj.com/content/19/4/153.abstract N2 - Commentary on: Ahmed A, Bourge RC, Fonarow GC, et al. Digoxin use and lower 30-day all-cause readmission for Medicare beneficiaries hospitalised for heart failure. Am J Med 2014;127:61–70.OpenUrlCrossRefPubMed The use of digoxin for the treatment of heart failure dates back to the 18th century, yet controversy remains about its safety and efficacy. The largest clinical trial of digoxin concluded that digoxin had no effect on mortality but did improve the rate of rehospitalisation for patients with chronic heart failure.1 With increasing focus on readmissions, there are limited data to understand the impact of digoxin initiated during hospitalisation for acute heart failure on postdischarge outcomes. The authors analysed data from chart abstractions and Medicare claims of patients hospitalised with acute heart failure to assess the impact of digoxin on postdischarge … ER -